Airsculpt Technologies price to free cash flow AIRS
Market value divided by free cash flow over the last twelve months, since 2023.
- Today, Nov 2, 2026
- 158×
- 4-year median
- 46.8×
- Against its 4-year history
- 78th
- percentile: 0 is its lowest day, 100 its highest
- 4-year range
- 15.0× to 420×
- Peer median
- 12.3×
Airsculpt Technologies' price to free cash flow is 158× as of Nov 2, 2026.
That is above its 4-year median of 46.8×, higher than on 78% of days in the last 4 years.
Over that time it ranged from 15.0× in May 2024 to 420× in Nov 2024.
The median for 4 hospital and care facility stocks of a similar size is 12.3×.
Price to free cash flow over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 158× | 40.0× | 394× |
| 2025 | 51.4× | 51.4× | 289× |
| 2024 | 270× | 15.0× | 420× |
| 2023 | 27.8× | 18.3× | 48.3× |
Against its peers
Companies in Medical - Care Facilities nearest Airsculpt Technologies' size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| AIRSAirsculpt Technologies | 158× |
| CYHCommunity Health Systems | n/m |
| VMDViemed Healthcare | 12.3× |
| SBCSBC Medical | 8.8× |
| OMDAOmada Health | 48.1× |
| Peer median | 12.3× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on Airsculpt Technologies
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.